Dogwood Therapeutics (DWTX) Stock Analysis
NASDAQHealthcareBiotechnology
What Dogwood Therapeutics does
Dogwood Therapeutics, Inc. is an emerging biotechnology firm dedicated to creating innovative antiviral treatments. Their primary goal is to address illnesses that stem from atypical immune reactions provoked by viral infections. Its leading therapeutic candidate, IMC-1, is a precise fixed-dose combination of famciclovir and celecoxib, engineered to combat fibromyalgia. Additionally, the company is advancing IMC-2, which blends valacyclovir and celecoxib, aiming to alleviate the array of symptoms linked to long COVID, including persistent fatigue, sleep disturbances, cognitive issues, pain, autonomic dysfunction, and anxiety. Previously operating as Virios Therapeutics, Inc., the organization adopted the name Dogwood Therapeutics, Inc. in October 2024. Established in 2012, the company maintains its main office in Alpharetta, Georgia.
Key metrics
ETFs linked to DWTX
Broad-market and Healthcare sector ETFs an investor holding Dogwood Therapeutics is often also exposed to. Open an ETF page to see its actual top holdings.
PortView Portfolio Insights
PortView analyzes how DWTX fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze DWTX in PortView →Similar companies
Frequently asked questions
- What is the ticker symbol for Dogwood Therapeutics?
- Dogwood Therapeutics trades under the ticker DWTX on NASDAQ.
- Which exchange is DWTX listed on?
- DWTX is listed on NASDAQ.
- What sector does Dogwood Therapeutics operate in?
- Dogwood Therapeutics is classified in the Healthcare sector (Biotechnology industry).
- How can PortView help analyze DWTX in a portfolio?
- PortView shows DWTX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.